1. Home
  2. RVMD vs LLYVA Comparison

RVMD vs LLYVA Comparison

Compare RVMD & LLYVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • LLYVA
  • Stock Information
  • Founded
  • RVMD 2014
  • LLYVA 1991
  • Country
  • RVMD United States
  • LLYVA United States
  • Employees
  • RVMD N/A
  • LLYVA N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • LLYVA Broadcasting
  • Sector
  • RVMD Health Care
  • LLYVA Industrials
  • Exchange
  • RVMD Nasdaq
  • LLYVA Nasdaq
  • Market Cap
  • RVMD 7.4B
  • LLYVA 7.1B
  • IPO Year
  • RVMD 2020
  • LLYVA N/A
  • Fundamental
  • Price
  • RVMD $39.66
  • LLYVA $78.44
  • Analyst Decision
  • RVMD Strong Buy
  • LLYVA
  • Analyst Count
  • RVMD 12
  • LLYVA 0
  • Target Price
  • RVMD $68.67
  • LLYVA N/A
  • AVG Volume (30 Days)
  • RVMD 1.7M
  • LLYVA 89.0K
  • Earning Date
  • RVMD 08-06-2025
  • LLYVA 01-01-0001
  • Dividend Yield
  • RVMD N/A
  • LLYVA N/A
  • EPS Growth
  • RVMD N/A
  • LLYVA N/A
  • EPS
  • RVMD N/A
  • LLYVA 0.27
  • Revenue
  • RVMD N/A
  • LLYVA N/A
  • Revenue This Year
  • RVMD N/A
  • LLYVA $7.29
  • Revenue Next Year
  • RVMD $241.39
  • LLYVA N/A
  • P/E Ratio
  • RVMD N/A
  • LLYVA $289.58
  • Revenue Growth
  • RVMD N/A
  • LLYVA N/A
  • 52 Week Low
  • RVMD $29.17
  • LLYVA $34.56
  • 52 Week High
  • RVMD $62.40
  • LLYVA $79.78
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 49.08
  • LLYVA 63.75
  • Support Level
  • RVMD $38.57
  • LLYVA $72.09
  • Resistance Level
  • RVMD $42.40
  • LLYVA $75.73
  • Average True Range (ATR)
  • RVMD 1.38
  • LLYVA 1.83
  • MACD
  • RVMD -0.16
  • LLYVA 0.27
  • Stochastic Oscillator
  • RVMD 28.46
  • LLYVA 84.63

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

About LLYVA Liberty Media Corporation Series A Liberty Live

Liberty Live Group would be engaged in the operations of Live Nation, and Liberty Media's planning for that group is to maximize the value of its investment in that company and the other assets attributed to the Liberty Live Group and to use the new Liberty Live common stock to make strategic acquisitions or for other capital raising initiatives.

Share on Social Networks: